Reminder of Class Action Lawsuit Against Integer Holdings
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1h ago
0mins
Should l Buy ITGR?
Source: Globenewswire
- Sales Guidance Cut: Integer Holdings lowered its full-year 2025 sales guidance to between $1.840 billion and $1.854 billion on October 23, 2025, falling short of expectations, with anticipated net sales growth for 2026 projected at -2% to 2%, significantly undermining investor confidence.
- Decline in New Product Sales: During the earnings call, management disclosed that sales of three new products, including two electrophysiology devices, are expected to decline in 2026 due to slower market adoption than forecasted, potentially impacting future revenue growth.
- Stock Price Plummet: Following the sales guidance cut, Integer's stock price dropped by $35.22, or 32.3%, to close at $73.89 on October 23, 2025, resulting in substantial losses for investors.
- Class Action Lawsuit Initiated: Glancy Prongay Wolke & Rotter LLP is reminding investors who purchased Integer stock between July 25, 2024, and October 22, 2025, to file a lead plaintiff motion by February 9, 2026, alleging that the company made materially misleading statements regarding its sales and market prospects.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ITGR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ITGR
Wall Street analysts forecast ITGR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ITGR is 93.38 USD with a low forecast of 75.00 USD and a high forecast of 140.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
10 Analyst Rating
4 Buy
6 Hold
0 Sell
Moderate Buy
Current: 86.040
Low
75.00
Averages
93.38
High
140.00
Current: 86.040
Low
75.00
Averages
93.38
High
140.00
About ITGR
Integer Holdings Corporation is a medical device contract development and manufacturing company. The Company serves the cardiac rhythm management, neuromodulation, and cardio and vascular markets. Its brands include Greatbatch Medical and Lake Region Medical. The Company’s Cardio & Vascular product line offers a range of components, subassemblies, and finished devices used in interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. Its interventional cardiology portfolio is focused primarily on the design, development and manufacture of catheter and wire-based technologies intended to diagnose and treat cardiac disease. Its electrophysiology products include devices used by electrophysiologists and interventional cardiologists for the treatment of cardiac arrythmias, such as atrial fibrillation.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Integer Holdings Faces Class Action Securities Lawsuit
- Lawsuit Background: Levi & Korsinsky LLP has notified investors that Integer Holdings Corporation is facing a class action securities lawsuit aimed at recovering losses for investors affected between July 25, 2024, and October 22, 2025.
- Allegations of False Statements: The lawsuit alleges that Integer materially overstated its competitive position in the rapidly growing electrophysiology manufacturing market and concealed deteriorating sales of its electrophysiology devices, misleading investors about the company's prospects.
- Market Impact: The positive statements regarding the company's business and operations are deemed materially false and misleading, potentially leading to significant financial losses for investors and adversely affecting the company's stock price and market reputation.
- Participation Conditions: Affected investors must request to be appointed as lead plaintiff by February 9, 2026, and participation in the lawsuit incurs no costs, indicating the case could have significant implications for investor rights.
See More
Reminder of Class Action Lawsuit Against Integer Holdings
- Sales Guidance Cut: Integer Holdings lowered its full-year 2025 sales guidance to between $1.840 billion and $1.854 billion on October 23, 2025, falling short of expectations, with anticipated net sales growth for 2026 projected at -2% to 2%, significantly undermining investor confidence.
- Decline in New Product Sales: During the earnings call, management disclosed that sales of three new products, including two electrophysiology devices, are expected to decline in 2026 due to slower market adoption than forecasted, potentially impacting future revenue growth.
- Stock Price Plummet: Following the sales guidance cut, Integer's stock price dropped by $35.22, or 32.3%, to close at $73.89 on October 23, 2025, resulting in substantial losses for investors.
- Class Action Lawsuit Initiated: Glancy Prongay Wolke & Rotter LLP is reminding investors who purchased Integer stock between July 25, 2024, and October 22, 2025, to file a lead plaintiff motion by February 9, 2026, alleging that the company made materially misleading statements regarding its sales and market prospects.
See More
Integer Holdings Corporation Securities Class Action Reminder
- Deadline for Claims: Investors must file lead plaintiff applications by February 9, 2026, to participate in the securities class action against Integer Holdings Corporation if they purchased shares between July 25, 2024, and October 22, 2025, indicating potential widespread impact on investor rights.
- Earnings Warning Impact: On October 23, 2025, Integer lowered its full-year 2025 sales guidance to between $1.840 billion and $1.854 billion, significantly below analyst expectations, with projected net sales growth of -2% to 2% for 2026, suggesting slower market adoption of its products and likely diminishing investor confidence.
- Stock Price Volatility: Following the earnings warning, Integer's stock plummeted from $109.11 per share on October 22, 2025, to $73.89 per share, a decline of over 32%, reflecting strong market concerns about the company's future performance and potential impacts on its financing capabilities.
- Legal Implications: The case, filed by the West Palm Beach Firefighters’ Pension Fund, alleges that Integer and certain executives failed to disclose material information during the class period, violating federal securities laws, which could expose the company to significant legal liabilities and financial repercussions.
See More
Integer Holdings Faces Shareholder Investigation Over Alleged Misconduct
- Shareholder Investigation Initiated: Grabar Law Office is investigating Integer Holdings Corp. for potential breaches of fiduciary duties by its executives, allowing shareholders who purchased before July 25, 2024, to seek corporate reforms and fund recovery.
- False Statements Allegations: A recently filed securities fraud class action claims that Integer failed to disclose its true competitive position in the EP manufacturing market, severely undermining shareholder confidence in the company's business and prospects.
- Sales Decline Risks: Despite claims of strong visibility into customer demand, the company is experiencing a sustained deterioration in sales of its EP devices, indicating a significant gap between market performance and corporate messaging that could impact future revenue growth.
- Legal Consequences Risk: Due to the aforementioned false statements, shareholders may face financial losses, and the company could incur legal liabilities, further affecting its market reputation and stock price performance.
See More
Integer Holdings Corporation Faces Class Action Lawsuit for Securities Fraud
- Lawsuit Background: Bleichmar Fonti & Auld LLP has filed a class action lawsuit against Integer Holdings Corporation and certain executives for securities fraud, leading to a significant stock drop and raising serious concerns about the company's financial transparency among investors.
- Stock Price Plunge: Integer disclosed on October 23, 2025, that it lowered its 2025 sales guidance to between $1.840 billion and $1.854 billion, well below analyst expectations, causing its stock price to plummet from $109.11 to $73.89, a decline of over 32%, which directly impacted investor confidence.
- False Market Demand Claims: The lawsuit alleges that Integer repeatedly overstated the demand and sales growth for its electrophysiology devices, while actual sales had sharply declined, indicating potential legal and financial repercussions due to misleading statements about market performance.
- Legal Consequences and Investor Rights: Investors have until February 9, 2026, to apply to lead the case, with BFA offering representation on a contingency fee basis, highlighting the firm's commitment to protecting investor rights and potentially influencing its future legal strategies and market reputation.
See More
Integer Holdings Class Action Reminder
- Class Action Notice: Rosen Law Firm reminds investors who purchased Integer Holdings stock between July 25, 2024, and October 22, 2025, to apply as lead plaintiffs by February 9, 2026, to potentially receive compensation without any out-of-pocket costs.
- Lawsuit Background: The lawsuit alleges that Integer overstated its competitive position in the electrophysiology market and misrepresented customer demand visibility, leading to investor losses when the truth emerged, indicating significant misguidance regarding the company's growth potential in its cardiovascular segment.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest settlement against a Chinese company, highlighting its successful track record; investors should be cautious in selecting legal counsel to ensure they receive qualified representation.
- Investor Action Steps: Investors can visit the Rosen Law Firm website or call the toll-free number for more information, and although a class has not yet been certified, they may choose to retain counsel or remain absent class members to preserve their rights to potential recovery.
See More
Integer Holdings Faces Class Action Securities Lawsuit
- Lawsuit Background: Levi & Korsinsky LLP has notified investors that Integer Holdings Corporation is facing a class action securities lawsuit aimed at recovering losses for investors affected between July 25, 2024, and October 22, 2025.
- Allegations of False Statements: The lawsuit alleges that Integer materially overstated its competitive position in the rapidly growing electrophysiology manufacturing market and concealed deteriorating sales of its electrophysiology devices, misleading investors about the company's prospects.
- Market Impact: The positive statements regarding the company's business and operations are deemed materially false and misleading, potentially leading to significant financial losses for investors and adversely affecting the company's stock price and market reputation.
- Participation Conditions: Affected investors must request to be appointed as lead plaintiff by February 9, 2026, and participation in the lawsuit incurs no costs, indicating the case could have significant implications for investor rights.
See More
Reminder of Class Action Lawsuit Against Integer Holdings
- Sales Guidance Cut: Integer Holdings lowered its full-year 2025 sales guidance to between $1.840 billion and $1.854 billion on October 23, 2025, falling short of expectations, with anticipated net sales growth for 2026 projected at -2% to 2%, significantly undermining investor confidence.
- Decline in New Product Sales: During the earnings call, management disclosed that sales of three new products, including two electrophysiology devices, are expected to decline in 2026 due to slower market adoption than forecasted, potentially impacting future revenue growth.
- Stock Price Plummet: Following the sales guidance cut, Integer's stock price dropped by $35.22, or 32.3%, to close at $73.89 on October 23, 2025, resulting in substantial losses for investors.
- Class Action Lawsuit Initiated: Glancy Prongay Wolke & Rotter LLP is reminding investors who purchased Integer stock between July 25, 2024, and October 22, 2025, to file a lead plaintiff motion by February 9, 2026, alleging that the company made materially misleading statements regarding its sales and market prospects.
See More
Integer Holdings Corporation Securities Class Action Reminder
- Deadline for Claims: Investors must file lead plaintiff applications by February 9, 2026, to participate in the securities class action against Integer Holdings Corporation if they purchased shares between July 25, 2024, and October 22, 2025, indicating potential widespread impact on investor rights.
- Earnings Warning Impact: On October 23, 2025, Integer lowered its full-year 2025 sales guidance to between $1.840 billion and $1.854 billion, significantly below analyst expectations, with projected net sales growth of -2% to 2% for 2026, suggesting slower market adoption of its products and likely diminishing investor confidence.
- Stock Price Volatility: Following the earnings warning, Integer's stock plummeted from $109.11 per share on October 22, 2025, to $73.89 per share, a decline of over 32%, reflecting strong market concerns about the company's future performance and potential impacts on its financing capabilities.
- Legal Implications: The case, filed by the West Palm Beach Firefighters’ Pension Fund, alleges that Integer and certain executives failed to disclose material information during the class period, violating federal securities laws, which could expose the company to significant legal liabilities and financial repercussions.
See More
Integer Holdings Faces Shareholder Investigation Over Alleged Misconduct
- Shareholder Investigation Initiated: Grabar Law Office is investigating Integer Holdings Corp. for potential breaches of fiduciary duties by its executives, allowing shareholders who purchased before July 25, 2024, to seek corporate reforms and fund recovery.
- False Statements Allegations: A recently filed securities fraud class action claims that Integer failed to disclose its true competitive position in the EP manufacturing market, severely undermining shareholder confidence in the company's business and prospects.
- Sales Decline Risks: Despite claims of strong visibility into customer demand, the company is experiencing a sustained deterioration in sales of its EP devices, indicating a significant gap between market performance and corporate messaging that could impact future revenue growth.
- Legal Consequences Risk: Due to the aforementioned false statements, shareholders may face financial losses, and the company could incur legal liabilities, further affecting its market reputation and stock price performance.
See More
Integer Holdings Corporation Faces Class Action Lawsuit for Securities Fraud
- Lawsuit Background: Bleichmar Fonti & Auld LLP has filed a class action lawsuit against Integer Holdings Corporation and certain executives for securities fraud, leading to a significant stock drop and raising serious concerns about the company's financial transparency among investors.
- Stock Price Plunge: Integer disclosed on October 23, 2025, that it lowered its 2025 sales guidance to between $1.840 billion and $1.854 billion, well below analyst expectations, causing its stock price to plummet from $109.11 to $73.89, a decline of over 32%, which directly impacted investor confidence.
- False Market Demand Claims: The lawsuit alleges that Integer repeatedly overstated the demand and sales growth for its electrophysiology devices, while actual sales had sharply declined, indicating potential legal and financial repercussions due to misleading statements about market performance.
- Legal Consequences and Investor Rights: Investors have until February 9, 2026, to apply to lead the case, with BFA offering representation on a contingency fee basis, highlighting the firm's commitment to protecting investor rights and potentially influencing its future legal strategies and market reputation.
See More
Integer Holdings Class Action Reminder
- Class Action Notice: Rosen Law Firm reminds investors who purchased Integer Holdings stock between July 25, 2024, and October 22, 2025, to apply as lead plaintiffs by February 9, 2026, to potentially receive compensation without any out-of-pocket costs.
- Lawsuit Background: The lawsuit alleges that Integer overstated its competitive position in the electrophysiology market and misrepresented customer demand visibility, leading to investor losses when the truth emerged, indicating significant misguidance regarding the company's growth potential in its cardiovascular segment.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest settlement against a Chinese company, highlighting its successful track record; investors should be cautious in selecting legal counsel to ensure they receive qualified representation.
- Investor Action Steps: Investors can visit the Rosen Law Firm website or call the toll-free number for more information, and although a class has not yet been certified, they may choose to retain counsel or remain absent class members to preserve their rights to potential recovery.
See More
